Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected p...

by Fukuoka M., Wu Y., Thongprasert S., Sunpaweravong P., Leong S., Sriuranpong V., Chao T., Nakagawa K., Chu D., Saijo N.
Published 2017

Efficacy according to blind independent central review: Post-hoc analyses from the phase III, randomized, multicenter, IPASS study of first-line gefitinib versus carboplatin/paclit...

by Wu Y., Saijo N., Thongprasert S., Yang J., Han B., Margono B., Chewaskulyong B., Sunpaweravong P., Ohe Y., Ichinose Y., Yang J., Mok T., Young H., Haddad V., Rukazenkov Y., Fukuoka M.
Published 2017

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer

by Shitara, K., Fleitas, T., Kawakami, H., Curigliano, G., Narita, Y., Wang, F., Wardhani, S. O., Basade, M., Rha, S. Y., Zamaniah, W. I. Wan, Sacdalan, D. L., Ng, M., Yeh, K. H., Sunpaweravong, P., Sirachainan, E., Chen, M. -h., Yong, W. P., Peneyra, J. L., Ibtisam, M. N., Lee, K. -w., Krishna, V., Pribadi, R. R., Li, J., Lui, A., Yoshino, T., Baba, E., Nakayama, I., Pentheroudakis, G., Shoji, H., Cervantes, A., Ishioka, C., Smyth, E.
Published 2024